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Abstract
Background: The aim of this study was to evaluate whether variant meso-Rex bypass with transposition of abdominal
autogenous vein can be used as an alternative treatment modality for selected patients with symptomatic extrahepatic
portal vein obstruction.
Methods: This was a retrospective review of six consecutive patients who received this alternative procedure for the
treatment of symptomatic portal hypertension secondary to idiopathic extrahepatic portal vein obstruction. Their clinical
characteristics, operative procedures and outcomes were analyzed retrospectively.
Results: The procedure was attempted in six patients, and all had a patent shunt established by intraoperative
portography at the end of the procedure; the coronary vein was used in four patients and the inferior mesenteric
vein was used in two. During the median period of 23.5 months (range 10–30 months), follow-up was uneventful
except one patient; reduced portal hypertension and no new episodes of gastrointestinal bleeding were observed in
all patients, with the exception of one patient with shunt stenosis and recurrent varix bleeding who had to undergo
endovascular treatment to restore portal vein blood flow. Technical and clinical success was achieved in all patients.
Conclusions: This procedure could be used safely and effectively to treat selected patients with portal hypertension
secondary to extrahepatic portal vein obstruction.
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Background
For the management of idiopathic extrahepatic portal vein
obstruction (EHPVO), the meso-Rex bypass (MRB) re-
stores portal inflow to the liver by inserting a venous con-
duit between a splanchnic vein and the intrahepatic left
portal vein (PV) branch in the Rex fossa. This procedure
was initially indicated for the treatment of extrahepatic PV
thrombosis following liver transplantation in children, but
has been successfully used to treat non-transplant patients
with thrombosis caused by other etiologies [1–5]. The
standard MRB technique uses the internal jugular vein
graft of the patient to restore hepatopetal flow, and results
in satisfactory long-term patency and a significantly re-
duced rate of clinical complications [1–5]. However, inevit-
ably, this procedure requires neck exploration and sacrifice
of the internal jugular vein, and some reports have men-
tioned problems secondary to the procurement of the
internal jugular vein [5, 6].
Previously, we described a method involving the trans-
position of a coronary vein, which is enlarged in most cases
of portal hypertension, as an alternative to the standard
MRB technique [7]. The aim of this study was to evaluate
whether variant MRB with transposition of abdominal
autogenous vein is a safe and effective treatment modality
in selected patients with symptomatic EHPVO who are
refractory to conservative management.
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Methods
This observational study included six consecutive patients
who presented with symptomatic portal hypertension sec-
ondary to idiopathic EHPVO and underwent variant MRB
with transposition of abdominal autogenous vein at our
hospital. The study protocol (Asan Medical Center IRB
No. 2013–1068) was approved by the hospital Institutional
Review Board, and all the guardians and two (Patients 1
and 3) of the patients provided written informed consent.
Consent to publish all of the information provided in
Table 1 was also obtained from all the participants.
The male-to-female ratio was 5:1, and the median age at
surgery was 11.5 years (range 1–20 years). All patients had
a history of upper gastrointestinal bleeding, splenomegaly,
severe hypersplenism, or some combination thereof. Both
Doppler ultrasonography and computed tomography
(CT) angiography were done to assess the intrahepatic
PV. A preoperative percutaneous transhepatic liver needle
biopsy was performed under general anesthesia to exclude
significant parenchymal hepatic fibrosis.
The surgical technique used was described previously
[7]. If the coronary vein had an adequate diameter and
flow in the hepatopetal direction, this vein was fully mobi-
lized, divided, and then transposed to the ventral portion
of the intrahepatic left PV to which it was anastomosed
end-to-side using non-absorbable monofilament inter-
rupted sutures. If there was no adequate coronary vein,
the inferior mesenteric vein was used. Intraoperative por-
tography confirmed adequate portal blood flow into the
liver, and the remaining large portosystemic shunts were
embolized with coils to augment portal blood flow to the
liver, if required. Combined splenectomy was performed
in patients with massive splenomegaly.
After the operation, patients were anticoagulated with a
regimen of low molecular weight heparin for 14 days
followed by orally administered warfarin for 3 to 6 months.
All patients were routinely followed using Doppler ultra-
sonography to assess shunt patency on day 0, 1, and 4, and
CT angiography on day 5. After discharge, Doppler
ultrasonography was performed to assess shunt patency at
1, 3, 6, and 12 months. Routine blood and biochemical
parameters were also evaluated at 1, 3, 6, and 12 months,
and each year thereafter.
Success of the variant MRB was defined as shunt patency
at 6-month follow-up, as assessed by Doppler ultrasonog-
raphy with visualization of the shunt without stenosis [4].
If a patient had a repeat intervention that was successful in
dilating a stenosed or thrombosed shunt, the variant MRB
procedure was considered a success. On the other hand, if
repeated attempts at reperfusion of a stenosed or throm-
bosed shunt were unsuccessful, the procedure was consid-
ered a failure.
Results and discussion
The characteristics of the patients are summarized in
Table 1. Six consecutive patients showed symptomatic
portal hypertension secondary to idiopathic EHPVO dur-
ing the study period. None of them had a familial history
of thrombosis or neonatal history of umbilical vein
catheterization. Combined anomalies were noted in three
patients. The first clinical manifestation was varix bleeding
in five patients and hypersplenism in one patient at a me-
dian age of 24 months (range 10 months–14 years). Pre-
operative Doppler ultrasonography and CT angiography
revealed thrombosis or cavernous transformation of the
main PV in all patients (Fig. 1); two patients had an intra-
hepatic PV that was adequate for shunting, but blood flow
in the left PV in the other four patients was inadequate. In
these four patients, patency was verified by surgical
exploration.
A variant MRB with transposition of abdominal autogen-
ous vein was attempted in six patients (Fig. 2), and all
patients had a patent shunt established by intraoperative
portography (Fig. 3); the coronary vein was used in four
patients and the inferior mesenteric vein was used in two.
Intraoperative embolization of the remaining portosystemic
shunts was done with coils to augment portal blood flow to
the liver in four patients, and combined splenectomy was












(months)Patient Sex/age (yr) Graft type Outcome
1 M/20 - EV, S, HS Absent CV + + 30 Good evolution
2a M/1 + EV, S Present CV + - 30 Good evolution
3 M/19 - EV, S, HS Absent CV + - 24 Good evolution
4 M/10 - EV, S, HS Present IMV + - 23 Good evolution
5 F/4 + EV, S, HS Absent IMV - - 10 Good evolution
6b M/13 + EV, S, HS Absent CV - + 10 Good evolution
Combined anomalies: Patient 2, dextrocardia and intestinal malrotation; Patients 5, congenital heart disease; Patient 6, imperforate anus
Preoperative Duplex USG: Present, visualization of intrahepatic portal vein; Absent, non-visualization of intrahepatic portal vein
EV esophageal varix bleeding, S splenomegaly, HS hypersplenism, USG ultrasonography, CV coronary vein, IMV inferior mesenteric vein
aPercutaneous transluminal angioplasty at 19 months after meso-Rex bypass
bPast history of distal spleno-renal shunt operation at 58 months before meso-Rex bypass
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performed in two patients because of massive splenomeg-
aly. Postoperative recovery was rapid and uneventful in all
patients. The results of liver function tests were within
normal ranges and normal portal blood flow was observed
by Doppler ultrasonography and CT angiography (Fig. 4).
There was no operation-related morbidity or mortality.
Long-term patency was achieved in all patients as con-
firmed by follow-up Doppler ultrasonography and CT
angiography. During the median period of 23.5 months,
follow-up was uneventful except one patient; portal hyper-
tension showed signs of improvement and no new epi-
sodes of gastrointestinal bleeding occurred. There was one
exception; one patient showed recurrent varix bleeding
(Patient 2) at 19 months after variant MRB and shunt
stenosis on Doppler ultrasonography. This patient re-
ceived endovascular treatment, which was successful in
restoring portal blood flow. In this study, of the six patients
who underwent a variant MRB with transposition of
abdominal autogenous vein, technical and clinical success
was achieved in all patients. There was no long-term
operation-related complication.
The incidence and natural history of EHPVO have not
been completely characterized; however, morbidity has
been mainly linked to symptoms of portal hypertension
[3–8]. Despite conservative treatment, patients who per-
sistently present with clinically significant symptoms of
portal hypertension are directed toward surgery options,
including MRB, which is the treatment of choice to
restore physiologic PV blood flow to the liver [3–11].
This technique not only effectively resolves or prevents all
of the known complications of EHPVO, but also shows
metabolic benefits over various portosystemic shunt oper-
ations [3–8].
For successful application of the MRB, eligible patients
must fulfill two preconditions; the hepatic structure
must be within normal limits and the umbilical portion
of the left PV must stay patent. In patients with EHPVO,
the initial thrombotic process seems to mainly involve the
Fig. 1 Preoperative computed tomographic angiography. Illustration: Preoperative computed tomographic angiography images showing an obliterated
main (black arrow) and left (white arrow) intrahepatic portal vein
Fig. 2 Operative findings. Illustration: Operative findings showing the transposed coronary vein (white arrows) anastomosed end-to-side to the ventral
portion of the extrahepatic left portal vein (white arrowheads) using non-absorbable monofilament interrupted sutures
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PV trunk, to which it is limited under typical disease con-
ditions; a variable extension, either downstream into the
intrahepatic radicals, or upstream into the splanchnic sys-
tem, or both can be observed [5]. Although extension of
thrombosis to the intrahepatic left PV sometimes precludes
the use of a MRB, this technique is surgically feasible in
most patients without acute liver necrosis or liver fibrosis,
even when the intrahepatic left PV is poorly visible or not
seen at all on routine preoperative imaging studies [7, 8].
In such cases, the size and patency of the umbilical portion
of the left PV must be confirmed by surgical exploration.
Although a preoperative Doppler ultrasonography evalu-
ation did not indicate blood flow in the intrahepatic left
PV in four patients in our study, surgical exploration
revealed that the intrahepatic PVs were hypoplastic but
appropriate for shunting.
In the standard MRB technique consisting of bypass of
the thrombosed portal trunk via the interposition of a
graft between the superior mesenteric vein and the Rex
recessus, the patient’s internal jugular vein is the most
commonly used source of the vascular autograft, and the
implementation of this procedure has yielded excellent
results over the past two decades [9–13]. However, inev-
itably, this procedure requires neck exploration and
sacrifice of the internal jugular vein, and some reports
have mentioned problems secondary to the procurement
of the internal jugular vein [5, 6].
The current technique, using a transposed abdominal
autogenous vein as a conduit, without neck exploration, is
a potentially valuable modification of conventional MRB
in selected patients with an enlarged coronary or a patent
inferior mesenteric vein [14, 15]. It would be valuable in
relieving symptoms of portal hypertension and hypers-
plenism in non-transplant patients with EHPVO. Further-
more, this technique would simplify the operative
procedure as it involves only one vascular anastomosis;
thus, it decreases the total operating time, eliminates the
procurement of autologous veins, and reduces the need
for simultaneous embolization of large collaterals to aug-
ment portal blood flow.
Several limitations should be noted. The retrospective
nature of the analysis, the small sample size, and the short
follow-up duration make it particularly challenging to reach
definitive conclusions about the safety and efficacy of this
alternative technique. Since these data were collected from
a single institution, our results cannot be generalized to
other centers. Furthermore, the decision to perform a vari-
ant MRB was made by the surgeon based on the expected
level of the adequacy of an enlarged coronary or a patent
inferior mesenteric vein. To the best of our knowledge,
there is no general consensus regarding optimal criteria of
a suitable autogenous venous conduit for successful stand-
ard MRB or our current technique, because of its rarity.
Future prospective studies on larger cohorts are warranted.
Conclusions
In the present small series, we propose an alternative tech-
nique for the transposition of abdominal autogenous vein
Fig. 4 Follow-up computed tomographic angiography. Illustration: Follow-up computed tomographic angiography images showing increased portal
flow (white arrow) via the preserved variant meso-Rex bypass (black arrowheads)
Fig. 3 Intraoperative portography. Illustration: Intraoperative
portography at the end of the procedure showing a brisk flow to
the left intrahepatic portal vein (white arrow) via the variant meso-Rex
bypass (black arrowhead)
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for the management of EHPVO without a vascular conduit,
which simplifies the operative procedures. This technique
could be used safely and effectively to treat symptoms of
portal hypertension in most cases of EHPVO with an
enlarged coronary or a patent inferior mesenteric vein.
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